EP1509599A1 - Aldehyde deshydrogenase - Google Patents

Aldehyde deshydrogenase

Info

Publication number
EP1509599A1
EP1509599A1 EP03740161A EP03740161A EP1509599A1 EP 1509599 A1 EP1509599 A1 EP 1509599A1 EP 03740161 A EP03740161 A EP 03740161A EP 03740161 A EP03740161 A EP 03740161A EP 1509599 A1 EP1509599 A1 EP 1509599A1
Authority
EP
European Patent Office
Prior art keywords
subunit
molecular weight
production
aldehyde dehydrogenase
sorbosone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03740161A
Other languages
German (de)
English (en)
Inventor
Tatsuo Hoshino
Taro Miyazaki
Teruhide Sugisawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Priority to EP03740161A priority Critical patent/EP1509599A1/fr
Publication of EP1509599A1 publication Critical patent/EP1509599A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/58—Aldonic, ketoaldonic or saccharic acids
    • C12P7/60—2-Ketogulonic acid

Definitions

  • the present invention concerns a novel enzyme, namely aldehyde dehydrogenase (hereinafter referred to as SNDH III), which is responsible for both of the conversions, from L-sorbosone to L-ascorbic acid (hereinafter referred to as vitamin C) at neutral pH, and from L-sorbosone to 2-keto-L-gulonic acid (hereinafter referred to as 2-KGA) at alkaline pH.
  • SNDH III aldehyde dehydrogenase
  • vitamin C L-ascorbic acid
  • 2-KGA 2-keto-L-gulonic acid
  • Vitamin C is one of very important and indispensable nutrient factor for human beings.
  • the metabolic pathways to produce vitamin C have been widely studied in various organisms.
  • the enzyme of the present invention is very useful for a novel vitamin C production process substitutive for the current process such as the Reichstein method (Helvetica Chimica Acta 17:311 (1934)).
  • the present invention provides a purified aldehyde dehydrogenase having the following physico-chemical properties: a) Molecular weight of 190,000 ⁇ 15,000 Da (consisting of a subunit structure of two ⁇ subunits and one ⁇ subunit) or molecular weight of 250,000 ⁇ 20,000 Da (consisting of a subunit structure of two ⁇ subunits and two ⁇ subunits), wherein the ⁇ subunit has a molecular weight of 75,000 ⁇ 3,000 Da and the ⁇ subunit has a molecular weight of 55,000 + 2,000 Da; b) Substrate specificity: active on aldehyde compounds, c) Cofactors: pyrroloquinoline quinone (PQQ) and heme c, d) Optimum pH: from about 6.5 to about 8.0 (for the production of vitamin C from L-sorbosone) or about 9.0 (for the production of 2-keto-L-gulonic acid from L- sorbo
  • the present invention is related to an aldehyde dehydrogenase with a molecular weight of 190,000 ⁇ 15,000 Da having the physico-chemical properties as described above. In a further embodiment, the present invention is related to an aldehyde dehydrogenase with a molecular weight of 250,000 ⁇ 20,000 Da having the physico- chemical properties as described above.
  • SNDH III of the present invention can be produced, for example, by isolation from a Gluconobacter or another microorganism capable of producing the aldehyde dehydrogenase having the above properties or it can be produced recombinanfly or by chemical synthesis.
  • Another object of the present invention provides a process for producing SNDH III described above, comprising cultivating a microorganism belonging to the genus Gluconobacter, which is capable of producing the aldehyde dehydrogenase having the above mentioned properties, in an aqueous nutrient medium under aerobic conditions, disrupting the cells of the microorganism, and isolating the aldehyde dehydrogenase from the cell-free extract of the disrupted cells of the microorganism.
  • the process for producing SNDH III as described above is carried out by cultivating a microorganism belonging to the genus Gluconobacter, which is capable of producing the aldehyde dehydrogenase having the above mentioned properties, wherein the reaction is carried out at a pH of from about 4.5 to about 9.0 and at a temperature of from about 20 to about 50°C.
  • the SNDH III thus produced is useful for both the production of vitamin C and 2-KGA.
  • Further object of the present invention provides a process for producing a carboxylic acid and/or its lactone from its corresponding aldose, comprising contacting the aldehyde with the purified SNDH III having the above mentioned properties, or cell- free extract prepared from a microorganism belonging to the genus Gluconobacter which is capable of producing the aldehyde dehydrogenase having the above mentioned properties in the presence of an electron acceptor.
  • aldose means an aldehyde with a hydroxyl group on every carbon atom except the carbonyl carbon atom.
  • aldoses as used herein include but are not limited to L-sorbosone, D- glucosone, D-glucose, and D-xylose.
  • a preferred lactone is vitamin C
  • a preferred carboxylic acid is 2-KGA
  • a preferred aldose is L-sorbosone.
  • the process for producing a carboxylic acid and/or its lactone from its corresponding aldose comprises contacting the aldehyde with the purified SNDH III having the above mentioned properties or with a cell-free extract prepared from a microorganism belonging to the genus Gluconobacter as defined above, wherein the molecular weight of said SNDH III is 190,000 ⁇ 15,000 Da.
  • the process for producing a carboxylic acid and/or its lactone from its corresponding aldose comprises contacting the aldehyde with the purified SNDH III having the above mentioned properties or with a cell-free extract prepared from a microorganism belonging to the genus Gluconobacter as defined above, wherein the molecular weight of said SNDH III is 250,000 ⁇ 20,000 Da.
  • the present invention is directed to a process for producing a carboxylic acid and/or its lactone from its corresponding aldose comprising contacting the aldehyde with the purified SNDH III having the above mentioned properties or with a cell-free extract prepared from a microorganism belonging to the genus Gluconobacter, which is capable of producing the aldehyde dehydrogenase having the above mentioned properties, wherein the reaction is carried out at a pH of from about 4.5 to about 9.0 and at a temperature of from about 20 to about 50°C.
  • the reaction is carried out preferably at a pH of from about 6.5 to about 8.0.
  • the reaction is carried out preferably at a pH of about 9.0.
  • the invention also features the use of the purified aldehyde dehydrogenase having the above mentioned properties in the process for the production of a carboxylic acid and/or its lactone from its corresponding aldose which comprises contacting the aldehyde with said purified aldehyde dehydrogenase or cell-free extract prepared from a microorganism belonging to the genus Gluconobacter which is capable of producing said aldehyde dehydrogenase in the presence of an electron acceptor.
  • SNDH III of the present invention catalyzes the oxidation of L-sorbosone to vitamin C and/or 2-KGA in the presence of an electron acceptor according to the following reaction equation:
  • the SNDH III does not work with oxygen as an electron acceptor. This was affirmed by the failure of SNDH III to convert L-sorbosone to vitamin C and/or 2-KGA using oxygen as a possible electron acceptor. Furthermore, no oxygen consumption was detected in the reaction mixture as detected with a dissolved oxygen probe. In addition NAD and NADP are not suitable electron acceptors. However, other conventional electron acceptors can be utilized in conjunction with SNDH III of this invention. Preferred electron acceptors are 2,6-dichlorophenolindophenol (DCIP), phenazine methosulfate (PMS), ferricyanide and cytochrome c. There is no minimum amount of electron acceptors which must be present for at least some of the aldehyde substrate to be converted to its corresponding acid. However, the amount of substrate which can be oxidized depends on the amount of the particular electron acceptor and its electron accepting characteristics.
  • the enzyme assay was performed as follows:
  • the reaction mixture consisted of 1.0 mM PMS, 25 mM potassium phosphate buffer (pH 7.0), 1.0 ⁇ M PQQ, 1.0 mM CaCl 2 , 50 mM L-sorbosone and enzyme solution in a final volume of 100 ⁇ l water, said reaction mixture was prepared just before the assay. The reaction was carried out at 30°C for 60 minutes unless otherwise stated.
  • the amount of produced 2-KGA was measured by HPLC as described above.
  • One unit of the enzyme activity for each production was defined as the amount of the enzyme which produces 1 mg of vitamin C and 2-KGA, respectively, in the reaction mixture.
  • the reaction mixture consisted of 0.1 mM DCIP, 1.0 mM PMS, 50 mM potassium phosphate buffer (pH 7.0), 1.0 ⁇ M PQQ, 2-100 mM substrate (L-sorbosone, D- glucosone, D-glucose, etc.) and enzyme solution in a final volume of 100 ⁇ l water, said reaction mixture was prepared just before the assay.
  • the reaction was started at 25°C with L-sorbosone, and the enzyme activity was measured as the initial reduction rate of DCIP at 600 nm.
  • One unit of the enzyme activity was defined as the amount of the enzyme catalyzing the reduction of 1 ⁇ mol DCIP per minute.
  • the extinction coefficient of DCIP at pH 7.0 was taken as 14.2 mM "1 .
  • a reference cuvette contained all the above constituents except for L-sorbosone.
  • the protein concentration was measured with Protein Assay CBB Solution (Nacalai tesque, Inc. Kyoto, Japan).
  • the substrate specificity of the enzyme was determined using the same enzyme assay method as described under lb) above with the exception of using 100 mM potassium phosphate (pH 7.5) or 100 mM Tris-HCl (pH 9.0) as buffer.
  • the relative activity of SNDH III for D-glucosone (2 mM), D-glucose (100 mM), and D-xylose (100 mM) was higher than that for L-sorbosone (2 mM) at both pH 7.5 and 9.0.
  • SNDH III of the present invention showed relatively high activity for the production of vitamin C at from about pH 6.5 to about 8.0 and high activity for the production of 2-KGA at a pH of about 9.0.
  • Each compound was added to the reaction mixture at a concentration of 1.0 M, with the exception that the concentrations of EDTA, NaN 3 and monoiodoacetate were 5.0 mM.
  • the molecular weight of the SNDH III was measured with a size exclusion gel column (TSK-gel G3000 SWXL; TOSOH Co., Akasaka 1-7-7, Minato-ku, Tokyo, Japan).
  • the enzyme showed two peaks corresponding to the apparent molecular weight of about 190,000 ⁇ 15,000 Da and about 250,000 ⁇ 20,000 Da on the chromatography.
  • SNDH III did not consist of two kinds of heterologous subunits having the molecular weight of 75,000 ⁇ 3,000 ( subunit) and 55,000 ⁇ 2,000 Da ( ⁇ subunit), respectively.
  • SNDH III comprises two kinds of subunit structures of the two ⁇ and one ⁇ subunits, or the two and two ⁇ subunits, in which the subunit has a molecular weight of 75,000 ⁇ 3,000 Da and the ⁇ subunit has a molecular weight of 55,000 ⁇ 2,000 Da. Both the trimeric and tetrameric forms of SNDH III are active.
  • the purified SNDH III (0.1 mg) in 50 ⁇ l of 100 mM NaH 2 PO 4 -HCl (pH about 1.0) was added by an equal volume of methanol and mixed well. The sample was centrifuged to remove a precipitate. The resulting supernatant was used for analysis of the prosthetic group.
  • the absorption spectrum of the extract was almost identical with an authentic sample of PQQ (Mitsubishi Gas Chemical, Japan). Its absorbance peaks were found at 251 and 348 nm.
  • the detection of heme c of the purified SNDH III was attempted by the reduced- minus-oxidized difference spectrum taken by an UN- VIS recording spectrophotometer (Shimadzu UV-2200; Shimadzu Co.).
  • S ⁇ DH III was suspended in 50 mM potassium phosphate buffer (pH 7.0) at a concentration of 50 ⁇ g/ml and S ⁇ DH III of dithionite- reduced form and ammonium persulfate-oxidized form were prepared to measure the difference spectrum.
  • the spectrum gave the difference maxima at 552 and 523 nm.
  • the velocity of the oxidizing reaction with various concentrations of L-sorbosone from 1 mM to 8 mM was measured to determine the Km value for L-sorbosone.
  • the Michaelis constants were calculated to be 6.5 mM and 16.8 mM at pHs of 7.5 and 9.0, respectively, from the Lineweaver-Burk plot based on the reaction velocity when DCIP was used as the electron acceptor for the reaction.
  • the purification of S ⁇ DH III is effected by any combination of known purification methods, such as ion exchange column chromatography, hydrophobic column chromatography, salting out and dialysis.
  • S ⁇ DH III provided by the present invention can be prepared by cultivating an appropriate microorganism in an aqueous nutrient medium under aerobic conditions, disrupting the cells of the microorganism and isolating and purifying the aldehyde dehydrogenase from the cell-free extract of the disrupted cells of the microorganism.
  • the microorganisms used for the process of the present invention are microorganisms belonging to the genus Gluconobacter which are capable of producing aldehyde dehydrogenase as defined herein before.
  • a preferred strain is Gluconobacter oxydans.
  • the strain most preferably used in the present invention is Gluconobacter oxydans DSM 4025, which was deposited at the Deutsche Sammlung von Mikroorganismen in G ⁇ ttingen (Germany), based on the stipulations of the Budapest Treaty, under DSM No. 4025 on March 17, 1987.
  • the depositor was The Oriental Scientific Instruments Import and Export Corporation for Institute of Microbiology, Academia Sinica, 52 San-Li-He Rd., Beijing, Peoples Republic of China.
  • the effective depositor was said Institute, of which the full address is The Institute of Microbiology, Academy of Sciences of China, Haidian, Zhongguancun, Beijing 100080, People's Republic of China.
  • aldehyde dehydrogenase as defined herein before which is derived from Gluconobacter oxydans having the identifying characteristics of the strain Gluconobacter oxydans DSM No. 4025 (FERM BP- 3812), a subculture or mutant thereof.
  • Mutants of G. oxydans DSM 4025 (FERM BP-3812) or a microorganism belonging to the genus Gluconobacter and having identifying characteristics of G. oxydans DSM 4025 (FERM BP-3812) may be obtained by treating the cells by means of, for instance, ultraviolet or X-ray irradiation, or a chemical mutagen such as nitrogen mustard or N- methyl-n'-nitro-N-nitrosoguanidine.
  • microorganism Any type of microorganism maybe used, for instance, resting cells, acetone treated cells, lyophilized cells, immobilized cells and the like to act directly on the substrate. Any means per se known as a method in connection with the incubation technique for microorganisms may be adopted through the use of aeration and agitated submerged fermentors is particularly preferred.
  • the preferred cell concentration range for carrying out the reaction is from about 0.01 g of wet cell weight per ml to 0.7 g of wet cell per ml, preferably from 0.03 g of wet cell per ml to 0.5 g of wet cell per ml.
  • the microorganism "Gluconobacter oxydans" also includes synonyms or basonyms of such species having the same physico-chemical properties, as defined by the International Code of Nomenclature of Prokaryotes.
  • G. oxydans DSM No. 4025 (FERM BP-3812) are as follows:
  • the microorganism may be cultured in an aqueous medium supplemented with appropriate nutrients under aerobic conditions.
  • the cultivation may be conducted at a pH of from about 4.0 to about 9.0, preferably from about 6.0 to about 8.0.
  • the cultivation period varies depending on the pH, temperature and nutrient medium to be used, and is preferably about 1 to 5 days.
  • the preferred temperature range for carrying out the cultivation is from about 13°C to about 36°C, preferably from about 18°C to about 33°C. A temperature of up to about 50°C might be also suitable for the cultivation of the microorganism.
  • the culture medium contains such nutrients as assimilable carbon sources, for example, glycerol, D-mannitol, D-sorbitol, erythritol, ribitol, xylitol, arabitol, inositol, dulcitol, D-ribose, D-fructose, D-glucose, and sucrose, preferably D- sorbitol, D-mannitol and glycerol; and digestible nitrogen sources such as organic substances, for example, peptone, yeast extract, baker's yeast, urea, amino acids, and corn steep liquor.
  • nutrients for example, glycerol, D-mannitol, D-sorbitol, erythritol, ribitol, xylitol, arabitol, inositol, dulcitol, D-ribose, D-fructose, D-glucose, and sucrose,
  • the culture medium usually contains inorganic salts, for example magnesium sulfate, potassium phosphate and calcium carbonate.
  • Cells are harvested from the liquid culture broth by centrifugation or filtration.
  • the harvested cells are washed with water, physiological saline or a buffer solution having an appropriate pH.
  • the washed cells are suspended in the buffer solution and disrupted by means of a homogenizer, sonicator or French press or by treatment with lysozyme and the like to give a solution of disrupted cells.
  • SNDH III is isolated and purified from the cell-free extract of disrupted cells, preferably from the soluble fraction of the microorganism.
  • a cell free extract can be obtained from the disrupted cells by any conventional technique, including but not limited to centrifugation.
  • SNDH III provided by the present invention is useful as a catalyst for the production of vitamin C and/or 2-KGA from L-sorbosone.
  • the reaction can be conducted at pH values of about 4.5 to about 9.0 for both of vitamin C production and 2-KGA production in the presence of an electron acceptor, for example DCIP, PMS and the like in a solvent such as phosphate buffer, Tris-buffer and the like.
  • an electron acceptor for example DCIP, PMS and the like
  • a solvent such as phosphate buffer, Tris-buffer and the like.
  • the pH is set at about 6.5 to about 8.0 and the temperature is set at about 20 to about 40°C.
  • 2-KGA production the best results are usually achieved if the pH is set at about 9.0 and the temperature is set at about 20 to about 50°C.
  • the concentration of L-sorbosone in a reaction mixture can vary depending upon other reaction conditions but, in general, is about 0.5 to 50 g/1, most preferably from about 1 to about 30 g/1.
  • SNDH III may also be used in an immobilized state with an appropriate carrier.
  • Any means of immobilizing enzymes generally known in the art may be used.
  • the enzyme maybe bound directly to a membrane, granules or the like of a resin having one or more functional groups, or it maybe bound to the resin through bridging compounds having one or more functional groups, for example glutaraldehyde.
  • the cultured cells are also useful for the production of carboxylic acids and/or its lactones from their corresponding aldoses, especially for the production of 2-KGA and/ or vitamin C from L-sorbosone.
  • the production of other carboxylic acids and/or its lactones from their corresponding aldoses is carried out under the same conditions, including substrate concentration, as the conversion of L-sorbosone to 2-KGA and/or vitamin C as described above.
  • Gluconobacter oxydans DSM No. 4025 (FERM BP-3812) was grown on an agar plate containing 5.0% D-mannitol, 0.25% MgSO « 7H 2 0, 1.75% corn steep liquor, 5.0% baker's yeast, 0.5% urea, 0.5% CaCO 3 and 2.0% agar at 27°C for 4 days.
  • One loopful of the cells was inoculated into 50 ml of a seed culture medium containing 2% L-sorbose, 0.2% yeast extract, 0.05% glycerol, 0.25% MgSO 4 « 7H 2 O > 1.75% corn steep liquor, 0.5% urea and 1.5% CaCO 3 in a 500 ml Erlenmeyer flask, and cultivated at 30°C with 180 rpm for one day on a rotary shaker.
  • the seed culture thus prepared was used for inoculating 15 liters of medium, which contained 8.0% L-sorbose, 0.05% glycerol, 0.25% MgSO *7H O, 3.0% corn steep liquor, 0.4% yeast extract and 0.15% antifoam, in a 30-1 jar fermentor.
  • the fermentation parameters were 800 rpm for the agitation speed and 0.5 wm (volume of air / volume of medium / minute) for aeration at a temperature of 30°C.
  • the pH was maintained at 7.0 with sodium hydroxide during the fermentation. After 48 hours of cultivation, 30 liters of the cultivated broth containing the cells of Gluconobacter oxydans DSM No.
  • a portion (64.2 g) of the cell paste was suspended with 280 ml of the buffer and passed through a French pressure cell press. After centrifugation to remove intact cells, the supernatant was designated as the cell-free extract, and the cell- free extract was centrifuged at 100,000 xg for 60 minutes. The resultant supernatant (227 ml) was designated as the soluble fraction of Gluconobacter oxydans DSM No. 4025 (FERM BP- 3812). After this fraction was dialyzed against the buffer, 105 ml of the dialyzed fraction having the specific activity for producing vitamin C from L-sorbosone of 0.107 unit/mg protein were used for the next purification step.
  • the dialysate (150 ml) was put on a column of DEAE-cellulose (Whatman DE-52, 3 x 50 cm; Whatman BioSystems Ltd., Springfield Mill, James Whatman Way, Maidstone, Kent, U.K.) equilibrated with the buffer and washed with the buffer to elute minor proteins. Then proteins bound to the resin were eluted stepwise with 0.28, 0.32, 0.36 M NaCl in the buffer. Major enzyme activity was eluted at 0.36 M NaCl. The active fractions (143 ml) were collected.
  • DEAE-cellulose Whatman DE-52, 3 x 50 cm; Whatman BioSystems Ltd., Springfield Mill, James Whatman Way, Maidstone, Kent, U.K.
  • a portion (127 ml) of the active fraction from the previous step was filtrated by an ultrafiltrator (Centriprep-10, Amicon; Amicon Inc. Cherry Hill Drive, Beverly, MA 01915, U.S.A.) to concentrate. After the concentrated sample (28 ml) was dialyzed against the buffer, 28 ml of the dialyzed fraction (31 ml) was put on a column of Carboxymethyl-cellulose (Whatman CM-52, 3 x 23 cm; Whatman BioSystems Ltd.) equilibrated with the buffer. The proteins that passed through the column without binding to the resin were collected.
  • the pooled active fractions (43 ml) were filtrated by an ultrafiltrator (Centriprep- 10) to concentrate.
  • a portion (9.5 ml) of the concentrated active fraction (10 ml ) from the previous step was put on a column of Q-sepharose (Pharmacia, 1.5 by 50 cm) equilibrated with the buffer. After the column was washed with the buffer containing 0.3 M NaCl, a linear gradient of NaCl from 0.3 to 0.6 M was added to the buffer.
  • the active fractions were eluted at NaCl concentrations ranging from 0.55 to 0.57 M.
  • the pooled active fractions (22 ml) from the previous step were filtrated by an ultrafiltrator (Centriprep-10) to concentrate. And the concentrated sample (3.0 ml) was dialyzed against the buffer. The dialyzed sample (3.5 ml) was put on a column of Q- sepharose (Pharmacia, 1.5 by 50 cm) equilibrated with the buffer. After the column was washed with the buffer containing 0.35 M NaCl, a linear gradient of NaCl from 0.35 to 0.7 M was added to the buffer. The active fractions were eluted at NaCl concentrations ranging from 0.51 to 0.53 M.
  • the pooled active fractions (20 ml) from the previous step were filtrated by an ultrafiltrator (Centriprep-10) to concentrate and desalt.
  • a portion (1.5 ml) of the concentrated and desalted (below 0.1 M NaCl) sample (2.0 ml) was put on a column of Sephacryl S-300 High Resolution (Pharmacia, 1.5 by 120 cm) equilibrated with the buffer containing 0.1M NaCl.
  • the active fractions (12 ml) were collected and dialyzed against the buffer.
  • the dialyzed active fraction from the previous step was filtrated by an ultrafiltrator (Centriprep-10) to concentrate.
  • a portion (1.5 ml) of the concentrated sample (1.75 ml) was added to the equal volume (1.5 ml) of the buffer containing 3 M ammonium sulfate (the final concentration: 1.5 M).
  • the supernatant was loaded on a column RESOURCE ISO (Pharmacia, 1.0 ml) equilibrated with the buffer containing 1.5 M ammonium sulfate.
  • the proteins were eluted with the buffer containing a linear gradient of ammonium sulfate from 1.5 to 0.75 M.
  • the active fractions corresponding to SNDH III were eluted at ammonium sulfate concentrations ranging from 1.15 to 1.13 M.
  • the active fractions were dialyzed against the buffer using dialysis cups (Dialysis-cup MWCO 8000, Daiichi pure chemicals, Nihonbashi 3-13-5, Chuo-ku, Tokyo, Japan). Afterward, the fractions were gathered and stored at -20°C.
  • One unit* of the enzyme was defined as the amount of enzyme which produces 1 mg of vitamin C per hour in the reaction mixture described in la) mentioned above.
  • the purified enzyme (0.12 mg/ml) with a specific activity of 34.5 units per mg protein for vitamin C production and a specific activity of 7.82 units per mg protein for 2-KGA production was used for the following analysis:
  • the molecular weight of the native SNDH III was estimated by high performance liquid chromatography using a size exclusion gel column (TSK gel G3000 SWXL column, 7.8 x 300 mm) equilibrated with 0.1 M potassium phosphate buffer (pH 7.0) containing 0.3 M NaCl at 280 nm and a flow rate of 1.5 ml per minute. Cyanocobalamin (1.35 kDa), myoglobin (17 kDa), ovalbumin (44 kDa), ⁇ -globulin (158 kDa) and thyroglobulin (670 kDa) were used as molecular weight standards.
  • the purified SNDH III showed two peaks having the molecular weight of 190,000 ⁇ 15,000 Da and 250,000 ⁇ 20,000 Da, respectively.
  • SNDH III According to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS- PAGE), SNDH III consisted of two kinds of subunits, which are one with a molecular weight of 75,000 + 3,000 Da and another with a molecular weight of 55,000 ⁇ 2,000 Da.
  • the reaction mixture containing the purified SNDH III (1.21 ⁇ g), L-sorbosone (50 mM), PMS (1 mM), CaCl 2 (1 mM) and PQQ (1 ⁇ M) in 100 ⁇ l of the buffer was incubated for 1 hour at 30°C.
  • the reaction products were analyzed on thin layer chromatography (Silica gel 60F 254 , MERCK, 64271 Darmstadt, Germany) and HPLC.
  • Two kinds of products, vitamin C and 2-KGA were obtained from the enzyme reaction.
  • Vitamin C the sample was assayed by an amino-column (YMC-Pack Polyamine-II, YMC, Inc.) on a HPLC system.
  • 2-KGA the sample was assayed by a C- 18 column (YMC-Pack Pro C18, YMC, Inc.) on a HPLC system.
  • Example 2 Effect of pH on the production of vitamin C or 2-KGA from L-sorbosone by SNDH III
  • the effect of pH for the enzyme reaction was tested.
  • the reaction mixture containing the purified SNDH III (607 ng), L-sorbosone (50 mM), PMS (1 mM), CaCl 2 (1 mM) and PQQ (1 ⁇ M) in 100 ⁇ l of the buffer (100 mM) was incubated for 1 hour at 30°C.
  • the reaction products were analyzed by HPLC. The result is shown in Table 4.
  • Example 3 Effect of temperature on the production of vitamin C or 2-KGA from L- sorbosone b SNDH III
  • the effect of temperature on the enzyme activity was tested.
  • the reaction mixture containing the purified SNDH III (607 ng), L-sorbosone (50 mM), PMS (1 mM), CaCl 2 (1 mM) and PQQ (1 ⁇ M) in 100 ⁇ l of 25 mM potassium phosphate buffer (pH 7.0) was incubated for 1 hour at various temperatures (20-60°C).
  • the reaction products were analyzed by HPLC. The result is shown in Table 5.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne un nouvel aldéhyde déshydrogénase qui possède les propriétés physico-chimiques suivantes: un poids moléculaire de 190,000 ± 15,000 Da qui comprend une structure sous-unitaire de deux sous-unités α et d'une sous-unité β, ou un poids moléculaire de 250,000 ± 20,000 Da qui comprend une structure sous-unitaire de deux sous-unités α et deux sous-unités β, parmi lesquelles la sous-unité α présente un poids moléculaire de 75,000 ± 3,000 Da et la sous-unité β présente un poids moléculaire de 55,000 ± 2,000 Da; une activité déshydrogénase sur L-sorbosone, D-glucosone, D-glucose et D-xylose; utilise comme cofacteur la pyrroloquinoléine quinone et hème c; présente un pH optimal compris entre environ 6,5 et environ 8,0 pour la production de vitamine C et un pH optimum d'environ 9,0 pour la production de l'acide 2-céto-L-gulonique à partir de L-sorbosone; et enfin, est inhibé par Co2+, Cu2+, Fe3+, Ni2+, Zn2+, Mg2+, monoiodoacétate, et l'azide de sodium.
EP03740161A 2002-06-06 2003-05-30 Aldehyde deshydrogenase Withdrawn EP1509599A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP03740161A EP1509599A1 (fr) 2002-06-06 2003-05-30 Aldehyde deshydrogenase

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP02012582 2002-06-06
EP02012582 2002-06-06
PCT/EP2003/005676 WO2003104445A1 (fr) 2002-06-06 2003-05-30 Aldehyde deshydrogenase
EP03740161A EP1509599A1 (fr) 2002-06-06 2003-05-30 Aldehyde deshydrogenase

Publications (1)

Publication Number Publication Date
EP1509599A1 true EP1509599A1 (fr) 2005-03-02

Family

ID=29724378

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03740161A Withdrawn EP1509599A1 (fr) 2002-06-06 2003-05-30 Aldehyde deshydrogenase

Country Status (5)

Country Link
EP (1) EP1509599A1 (fr)
JP (1) JP2005528917A (fr)
CN (1) CN1659275A (fr)
AU (1) AU2003274096A1 (fr)
WO (1) WO2003104445A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100347309C (zh) * 2002-09-27 2007-11-07 帝斯曼知识产权资产管理有限公司 生产维生素c的方法
CN104004776A (zh) 2003-08-14 2014-08-27 帝斯曼知识产权资产管理有限公司 对l-抗坏血酸进行微生物生产的方法
WO2006084644A2 (fr) * 2005-02-11 2006-08-17 Dsm Ip Assets B.V. Gene rcs 33
EP1846565A1 (fr) * 2005-02-11 2007-10-24 DSMIP Assets B.V. Gene rcs 21
EP1853715A1 (fr) * 2005-02-11 2007-11-14 DSMIP Assets B.V. Gene rcs 23

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1688499B1 (fr) * 1996-09-19 2010-12-29 DSM IP Assets B.V. Déshydrogénase d'alcool et d'aldéhyde
DE69821326T2 (de) * 1997-12-01 2004-11-18 Dsm Ip Assets B.V. Aldehyd-Dehydrogenase

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO03104445A1 *

Also Published As

Publication number Publication date
JP2005528917A (ja) 2005-09-29
AU2003274096A1 (en) 2003-12-22
WO2003104445A1 (fr) 2003-12-18
CN1659275A (zh) 2005-08-24

Similar Documents

Publication Publication Date Title
KR101031451B1 (ko) 비타민 ｃ의 생성 방법
JPH07182A (ja) アルコール／アルデヒド脱水酵素
EP0728840B1 (fr) Déshydrogénase de D-Sorbitol
US6242233B1 (en) Aldehyde dehydrogenase
Sugisawa et al. Isolation and characterization of a new vitamin C producing enzyme (l-gulono-γ-lactone dehydrogenase) of bacterial origin
US5250428A (en) L-gulono-gamma-lactone-dehydrogenase for producing vitamin C
EP1509599A1 (fr) Aldehyde deshydrogenase
US20050153412A1 (en) Aldehyde dehydrogenase II
US4902617A (en) Enzyme and process for producing the same
EP0790301B1 (fr) Aldéhyde déshydrogénase
JP2006503551A5 (fr)
EP1026257B1 (fr) Production d'acide L-ascorbique et d'acide D-érythorbique
JP4727033B2 (ja) チトクロームｃオキシダーゼ酵素複合体
JPH01202282A (ja) 酵素およびその製造方法
WO2004029267A9 (fr) Procede pour produire de l'acide l-ascorbique

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

17P Request for examination filed

Effective date: 20041115

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

18W Application withdrawn

Effective date: 20050222